B. Mason

发表

Breast cancer in the very young patient: a multidisciplinary case presentation.

D. Mintzer, J. Glassburn, B. Mason, 2002, The oncologist.

Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.

Z. Baloch, B. Mason, D. Sataloff, 1995, Journal of the American College of Surgeons.

The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.

T. Rebbeck, K. Nathanson, S. Domchek, 2008, Cancer research.

Levamisole: as adjuvant to cyclic chemotherapy in breast cancer.

H. F. Wood, B. Mason, E. J. Stephens, 1978, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

To screen or not to screen: lung and breast cancer

B. Mason, 2014 .

A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer.

A. Turrisi, B. Mason, D. Glover, 1988, International journal of radiation oncology, biology, physics.

Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.

D. Finkelstein, J. Ruckdeschel, B. Mason, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

From ATLAS to HORIZONTAL: musings on five key trials

B. Mason, 2013 .

Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292).

A. Benson, B. Miedema, S. Hamilton, 2022, Annals of surgical oncology.

Axillary—subclavian vein occlusion in patients with lung neoplasms

B. Mason, 1981, Cancer.

A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3‐times‐daily regimen to treat patients with recurrent metastatic breast cancer

G. Hortobagyi, D. Booser, W. Heim, 2010, Cancer.

Response to Seydel.

A. Turrisi, B. Mason, D. Glover, 1988, International journal of radiation oncology, biology, physics.

The use of an amniotic membrane graft to prevent postoperative adhesions.

G. Zund, R. Young, B. Mason, 1991, Fertility and sterility.

Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.

J. Sparano, E. Schwartz, J. Dutcher, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multicentric Glioblastoma Multiforme in a Patient with BRCA‐1 Invasive Breast Cancer

Robert A Lustig, J. Huse, P. Leroux, 2006, The breast journal.

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.

D. Ettinger, D. Finkelstein, J. Ruckdeschel, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.

D. Finkelstein, R. Hahn, D. Tormey, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of a phase II protocol for evaluation of new chemotherapeutic regimens in patients with inoperable non-small cell lung carcinoma (EST-2575, generation I).

M. Cohen, B. Mason, H. Lerner, 1981, Cancer treatment reports.

Periostitis associated with myelofibrosis

B. Mason, G. Schechter, A. Bernath, 1979, Cancer.

Half-body and local chest irradiation as consolidation following response to standard induction chemotherapy for disseminated small cell lung cancer: an Eastern Cooperative Oncology Group pilot report.

P. Rubin, J. Bennett, C. Scarantino, 1980, International journal of radiation oncology, biology, physics.

Effective control of cisplatin-induced nausea using high-dose steroids and droperidol.

B. Mason, R. Catalano, B. Grossman, 1982, Cancer treatment reports.

On the Need for Biopsy Confirmation at Suspected First Recurrence of Cancer

D. Mintzer, B. Mason, 2003, American journal of clinical oncology.

Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for the treatment of limited small cell lung cancer: a preliminary report.

A. Turrisi, B. Mason, D. Glover, 1988, Antibiotics and chemotherapy.

Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence

M. Schnall, K. Nathanson, M. Rosen, 2009, Breast Cancer Research and Treatment.

Patients with terminal cancer who use alternative therapies: their beliefs and practices

Patsy Yates, Gail M. Williams, A. Clavarino, 1993 .

Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancer.

V. Harvey, J. Cebon, B. Mason, 1990, British Journal of Cancer.

Concurrent twice-daily radiotherapy (XRT) — platinum (DDP) - etoposide (VP-16) for limited small cell lung cancer (SCLC): Update 1987

A. Turrisi, B. Mason, D. Glover, 1987 .

Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology Group.

A. Benson, M. Mulcahy, C. Falkson, 2011, Gastrointestinal cancer research : GCR.

A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer.

A. Turrisi, B. Mason, D. Glover, 1988 .

Upper hemibody and local chest irradiation as consolidation following response to high-dose induction chemotherapy for small cell bronchogenic carcinoma--a pilot study.

R. Creech, B. Mason, R. Catalano, 1982, Cancer treatment reports.

Unexpectedly good results, and no chemotherapy required

B. Mason, 2013 .